Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
11%
Ph not_applicable
5
56%
Ph phase_4
1
11%
Ph early_phase_1
1
11%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 3Large-scale testing
1(12.5%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
5(62.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(5)
Completed(2)
Other(2)

Detailed Status

Recruiting3
Not yet recruiting2
unknown2
Completed2

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (12.5%)
Phase 31 (12.5%)
Phase 41 (12.5%)
N/A5 (62.5%)

Trials by Status

not_yet_recruiting222%
recruiting333%
unknown222%
completed222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
OTHER
Total Trials
9